Real-Time Nanoscale Bacterial Detection Utilizing a 1DZnO Optical Nanobiosensor

IF 4 Q2 ENGINEERING, BIOMEDICAL
Rafael A. Salinas, Shirlley E. Martínez Tolibia, Andrés Galdámez-Martínez, Josué E. Romero, Laura J. García-Barrera, Abdú Orduña, Carlos David Ramos, Guillermo Santana Rodríguez, Ateet Dutt
{"title":"Real-Time Nanoscale Bacterial Detection Utilizing a 1DZnO Optical Nanobiosensor","authors":"Rafael A. Salinas,&nbsp;Shirlley E. Martínez Tolibia,&nbsp;Andrés Galdámez-Martínez,&nbsp;Josué E. Romero,&nbsp;Laura J. García-Barrera,&nbsp;Abdú Orduña,&nbsp;Carlos David Ramos,&nbsp;Guillermo Santana Rodríguez,&nbsp;Ateet Dutt","doi":"10.1002/anbr.202400013","DOIUrl":null,"url":null,"abstract":"<p>One-dimensional zinc oxide nanomaterials (1DZnO) have emerged as promising, cost-effective nanoplatforms with adjustable properties suitable for electrochemical and optical biosensing applications. In this work, modifications in the inherent photoluminescent response of 1DZnO are harnessed to develop a novel immunosensor tailored for detecting enteropathogenic <i>Escherichia coli</i>. This nanobiosensor demonstrates a modulation in photoluminescence signal, effectively responsive to analyte concentrations ranging from 1 × 10<sup>2</sup> to 1 × 10<sup>8</sup> CFU mL<sup>−1</sup>, with direct visualization of targeted bacterial cells over 1DZnO structures through scanning electron microscopy. The conceptualization of this nanobiosensor is focused on a real-time contact strategy that can significantly reduce processing and response times for pathogen detection, prospected for emergency scenarios. With this aim, the detection process unfolds in real time, with a mere 5–10 s interaction time, corroborated by the standard polymerase chain reaction approach. This synergistic validation underscores the reliability and precision of the developed biosensor. Notably, the utility of 1DZnO nanoplatforms extends beyond the realm of enteropathogenic <i>E. coli</i>, as the biosensing performance exhibited here holds promise for analogous applications involving other medically pertinent pathogens. This study paves the way for the broader implementation of 1DZnO-based biosensors in medical diagnostics, offering rapid, sensitive, and real-time detection capabilities.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"4 11","pages":""},"PeriodicalIF":4.0000,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202400013","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Nanobiomed Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/anbr.202400013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

One-dimensional zinc oxide nanomaterials (1DZnO) have emerged as promising, cost-effective nanoplatforms with adjustable properties suitable for electrochemical and optical biosensing applications. In this work, modifications in the inherent photoluminescent response of 1DZnO are harnessed to develop a novel immunosensor tailored for detecting enteropathogenic Escherichia coli. This nanobiosensor demonstrates a modulation in photoluminescence signal, effectively responsive to analyte concentrations ranging from 1 × 102 to 1 × 108 CFU mL−1, with direct visualization of targeted bacterial cells over 1DZnO structures through scanning electron microscopy. The conceptualization of this nanobiosensor is focused on a real-time contact strategy that can significantly reduce processing and response times for pathogen detection, prospected for emergency scenarios. With this aim, the detection process unfolds in real time, with a mere 5–10 s interaction time, corroborated by the standard polymerase chain reaction approach. This synergistic validation underscores the reliability and precision of the developed biosensor. Notably, the utility of 1DZnO nanoplatforms extends beyond the realm of enteropathogenic E. coli, as the biosensing performance exhibited here holds promise for analogous applications involving other medically pertinent pathogens. This study paves the way for the broader implementation of 1DZnO-based biosensors in medical diagnostics, offering rapid, sensitive, and real-time detection capabilities.

Abstract Image

利用 1DZnO 光学纳米生物传感器进行实时纳米级细菌检测
一维氧化锌纳米材料(1DZnO)是一种前景广阔、具有成本效益的纳米平台,其性能可调,适合电化学和光学生物传感应用。在这项工作中,利用 1DZnO 固有光致发光响应的变化,开发了一种新型免疫传感器,专门用于检测肠致病性大肠杆菌。这种纳米生物传感器显示了光致发光信号的调制,可有效响应 1 × 102 至 1 × 108 CFU mL-1 的分析物浓度,并可通过扫描电子显微镜直接观察 1DZnO 结构上的目标细菌细胞。这种纳米生物传感器的概念设计侧重于实时接触策略,可大大缩短病原体检测的处理和响应时间,有望用于紧急情况。为此,检测过程实时展开,只需 5-10 秒的交互时间,并通过标准聚合酶链反应方法加以证实。这种协同验证强调了所开发生物传感器的可靠性和精确性。值得注意的是,1DZnO 纳米平台的用途已超出肠致病性大肠杆菌的范畴,因为这里展示的生物传感性能为涉及其他医学相关病原体的类似应用带来了希望。这项研究为在医疗诊断中更广泛地应用基于 1DZnO 的生物传感器,提供快速、灵敏和实时的检测能力铺平了道路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advanced Nanobiomed Research
Advanced Nanobiomed Research nanomedicine, bioengineering and biomaterials-
CiteScore
5.00
自引率
5.90%
发文量
87
审稿时长
21 weeks
期刊介绍: Advanced NanoBiomed Research will provide an Open Access home for cutting-edge nanomedicine, bioengineering and biomaterials research aimed at improving human health. The journal will capture a broad spectrum of research from increasingly multi- and interdisciplinary fields of the traditional areas of biomedicine, bioengineering and health-related materials science as well as precision and personalized medicine, drug delivery, and artificial intelligence-driven health science. The scope of Advanced NanoBiomed Research will cover the following key subject areas: ▪ Nanomedicine and nanotechnology, with applications in drug and gene delivery, diagnostics, theranostics, photothermal and photodynamic therapy and multimodal imaging. ▪ Biomaterials, including hydrogels, 2D materials, biopolymers, composites, biodegradable materials, biohybrids and biomimetics (such as artificial cells, exosomes and extracellular vesicles), as well as all organic and inorganic materials for biomedical applications. ▪ Biointerfaces, such as anti-microbial surfaces and coatings, as well as interfaces for cellular engineering, immunoengineering and 3D cell culture. ▪ Biofabrication including (bio)inks and technologies, towards generation of functional tissues and organs. ▪ Tissue engineering and regenerative medicine, including scaffolds and scaffold-free approaches, for bone, ligament, muscle, skin, neural, cardiac tissue engineering and tissue vascularization. ▪ Devices for healthcare applications, disease modelling and treatment, such as diagnostics, lab-on-a-chip, organs-on-a-chip, bioMEMS, bioelectronics, wearables, actuators, soft robotics, and intelligent drug delivery systems. with a strong focus on applications of these fields, from bench-to-bedside, for treatment of all diseases and disorders, such as infectious, autoimmune, cardiovascular and metabolic diseases, neurological disorders and cancer; including pharmacology and toxicology studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信